Pairing Four Medicines to Help Treat Growing Meningiomas
About This Trial
This study looks at how well four different medicines work for patients with meningiomas that are growing or getting worse. The goal is to see if these medicines can help stop tumor growth by blocking certain enzymes. The medicines being tested are vismodegib, a FAK inhibitor, capivasertib, and abemaciclib, targeting specific changes in genes that affect tumor growth.
NCT ID
NCT02523014
Study Details
RecruitingInterventionalPhase 2
Conditions
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Eligibility
All sexesAdultOlder adult
Locations
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
NCT ID
NCT02523014
Study Details
RecruitingInterventionalPhase 2
Conditions
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Eligibility
All sexesAdultOlder adult
Locations
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming